The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate

Journal of Rehabilitation Medicine

Volumn 40, Issue 8, 2008, Pages 672-677

  Paone, Gregorino ^a,b   Serpilli, Manuela ^a,b   Girardi, Enrico ^c   Conti, Vittoria ^a   Principe, Rosastella ^d   Puglisi, Giovanni ^d   De Marchis, Laura ^e   Schmid, Giovanni ^b,f  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b The Don Gnocchi Foundation S Maria Della Pace   (Italy)

^c INMI L Spallanzani   (Italy)

^d S Camillo Forlanini Hospital   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Bupropion; Nicotine replacement therapy; Rehabilitation; Smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE PATCH;

ADULT; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; EXPIRED AIR; FEMALE; HEALTH SURVEY; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; REHABILITATION CARE; REHABILITATION CENTER; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; TREATMENT RESPONSE;

ADULT; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NICOTINE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REHABILITATION CENTERS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 53349176150     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0234     Document Type: Article

References (34)

1. Jorenby DE. Smoking cessation strategies for the 21st century. Circulation 2001; 104: 51-52.
2. Anderson JE, Jorenby DE, Scott WJ, Fiore MC. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest 2002; 121: 932-941.
3. Rivara FP, Ebel BE, Garrison MM, Christakis DA, Wiehe SE, Levy DT. Prevention of smoking-related deaths in the United States. Am J Prev Med 2004; 27: 118-125.
4. Fernandez E, Schiaffino A, Borras JM. Epidemiology of smoking in Europe. Salud Publica Mex 2002; 44 Suppl 1: S11-S19.
5. Hsu HC, Pwu RF. Too late to quit? Effect of smoking and smoking cessation on morbidity and mortality among the elderly in a longitudinal study. Kaohsiung J Med Sci 2004; 20: 484-491.
6. Twardella D, Kupper-Nybelen J, Rothenbacher D, Hahmann H, Wunsten B, Brenner H. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur Heart J 2004; 25: 2101-2108.
7. Edwards R. The problem of tobacco smoking. BMJ 2004; 328: 217-219.
8. Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized, controlled trial. Ann Intern Med 2001; 135: 423-433.
9. Dale LC, Glover ED, Sachs DP, Schroeder DR, Offord KP, Croghan IT, Hurt RD. Bupropion for smoking cessation. Predictors of successful outcome. Chest 2001; 119: 1357-1364.
10. Roddy E. Bupropion and other non-nicotine pharmacotherapies. BMJ 2004; 328: 509-511.
11. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-691.
12. Molyneux A. Nicotine replacement therapy. BMJ 2004; 328: 454-456.
13. Rigotti NA. Treatment of tobacco use and dependence. N Engl J Med 2002; 346: 506-512.
14. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task force: standardization of lung function testing. In Brusasco V, Crapo R, Viegi G, editors. Standardization of spirometry. Eur Respir J 2005; 26: 319-338.
15. Quanjier PH, Tammeling GJ, Cotes JE, Pederson OF, Peslin R, Yerault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Test, European Community for Steal and Coal. Official Statement of the European Respiratory Society. Eur Resp J Suppl 1993; 6: 5-40.
16. GOLD Committees, Global Initiative for Chronic Obstructive Lung Disease: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report [updated 2006]. Available from http://www.goldcopd.com
17. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav 1978; 3: 235-241.
18. Fung PR, Snape-Jenkinson SL, Godfrey MT, Love KW, Zimmerman PV, Yang IA, et al. Effectiveness of hospital-based smoking cessation. Chest 2005; 128: 216-223.
19. Zuccaro P, Caraffa G, Corti FM, Davoli M, Enea D, Fogliani V, et al, editors. Smoking cessation guidelines. Rome: Italian National Institute of Health Editions; 2003, p. 1-77.
20. Górecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 2003; 123: 1916-1923.
21. Wood-Baker R. Outcome of a smoking cessation programme run in a routine hospital setting. Intern Med J 2002; 32: 24-28.
22. Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med 2004; 19: 828-834.
23. Ferry L, Johnston JA. Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience. Int J Clin Pract 2003; 57: 224-230.
24. Hurt RD, Wolter TD, Rigotti N, Hays JT, Niaura R, Durcan MJ, et al. Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome. Addict Behav 2002; 27: 493-507.
25. Willemse B, Lesman-Leegte I, Timens W, Postma D, ten Hacken N. High Cessation rates of cigarette smoking in subjects with and without COPD. Chest 2005; 128: 3685-3687.
26. Wilson A, Hippisley-Cox J, Coupland C Coleman T, Britton J, Barrett S. Smoking cessation treatment in primary care. Prospective cohort study. Tobacco Control 2005; 14: 242-246.
27. Freund M, Campbell E, Paul C, Sakrouge R, Wiggers J. Smoking care provision in smoke-free hospitals in Australia. Prev Med 2005; 41: 151-158.
28. Young P, Dewse M, Fergusson W, Kolbe J. Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of non-adherence. Eur Respir J 1999; 13: 855-859.
29. Connor MC, O'Driscoll MF, Ms Donnell TJ. Should patients with chronic obstructive pulmonary disease (COPD) who expresses a desire to stop smoking be enrolled in pulmonary rehabilitation? Eur Respir J 1999; Supp1 14: 263s.
30. Karrer W. Pulmonary rehabilitation in Switzerland. Swiss Med Wkly 2005; 135: 71-75.
31. Brooks D, Lacasse Y, Goldstein RS. Pulmonary rehabilitation programs in Canada. Can Respir J 1999; 6: 55-63.
32. Lacasse Y, Maltais F, Goldstein RS. Smoking cessation in pulmonary rehabilitation: goal or prerequisite? J Cardiopulm Rehabil 2002; 22: 148-153.
33. Wilson N, Thomson G. New smoke-free environments legislation stimulates calls to a national Quitline. Tobacco Control 2005; 14: 287-288.
34. Gallus S, Zuccaro P, Colombo P, Apolone G, Pacifici R, Garattini S, et al. Effects of new smoking regulations in Italy. Ann Oncol 2006; 17: 346-347.